Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 471-480-0 | CAS number: 1645-83-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- September 2011 - November 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3800 (Reproduction and Fertility Effects)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries, Test Data for Registration of Agricultural Chemicals, 12 Nohsan No. 8147, Agricultural Production Bureau
- Version / remarks:
- November 20, 2000.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 471-480-0
- EC Name:
- -
- Cas Number:
- 1645-83-6
- Molecular formula:
- Hill formula: C3H2F4 CAS formula: C3H2F4
- IUPAC Name:
- (1E)-1,3,3,3-tetrafluoroprop-1-ene
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd
- Age at study initiation: (P) 40 - 46 days; (F1) 21 days
- Weight at study initiation: (P) Males: 180 - 262 g; Females: 123 - 193 g; (F1) Males: x-x g; Females: x-x g
- Fasting period before study: none
- Housing: barriered facility, plycarbonate cages w/bedding or stainless steel grid floor cages during mating. Animals were housed up to 4 per cage (by sex) during acclimation and pre-mating, one male and one female/cage during the mating period, and one female/cage during gestation and lactation (one dam with litter/cage)
- Use of restrainers for preventing ingestion (if dermal): no
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 18 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25
- Humidity (%): 29 to 70
- Air changes (per hr): none, supplied with filtered fresh air, passed to atmosphere with no re-circulation
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: To: 2011-09-15 to 2012-06-13
Administration / exposure
- Route of administration:
- inhalation: gas
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Whole body exposure chamber: 0.75 m3 chamber of stainless–steel and glass construction
- Method of holding animals in test chamber: Individual stainless steel mesh compartments
- Source and rate of air: From in-house compressed air system – breathing quality 147 to 149 L/minute
- System of generating particulates/aerosols: In-line flowmeters monitored continuously for generation feeds and diluent airflows. Chamber pressure differential monitored by Magnahelic set between 1 to 5 mm/H2O to ensure a slight negative pressure within the chamber to equate to 150 L/minute. - Details on mating procedure:
- - M/F ratio per cage: 1:1
- Length of cohabitation: up to 2 weeks
- Proof of pregnancy: vaginal plug or sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): Individually in polycarbonate cages with wood bedding
- Any other deviations from standard protocol: No - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Gas chromotography
- Duration of treatment / exposure:
- 6 hr/day
- Frequency of treatment:
- The F0 generation received HFO-1234ze 6 hr/day, 7 days/week for ten weeks before pairing, throughout pairing, gestation, lactation and until termination. The F1 generation received HFO-1234ze from weaning for a minimum of 10 weeks before pairing, throughout pairing, gestation and lactation and until termination. Exposure of pregnant females was not performed from gestation Day 20 to lactation Day 4.
- Details on study schedule:
- - F1 parental animals not mated until 10 weeks after selected from the F1 litters.
- Selection of parents from F1 generation when pups were 21 days of age.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2 000 ppm (nominal)
- Remarks:
- Group 2: Low dose
- Dose / conc.:
- 5 000 ppm (analytical)
- Remarks:
- Group 3: Mid dose
- Dose / conc.:
- 20 000 ppm (analytical)
- Remarks:
- Group 4: High dose.
- No. of animals per sex per dose:
- P0 generation: 28
F1 generation: 24 - Control animals:
- yes, sham-exposed
- Details on study design:
- - Dose selection rationale: Based on the 90 day study in rat where the high dose (15000 ppm) was considered a LOAEL for cardiac effects. A high dose of 20000 ppm was selected to better evaluate these and any other toxic effects. For details on cardiac effects reference is made to the section on details of materials and methods.
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: No
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Daily during the first week of treatment, twice weekly during Weeks 2 to 4 (middle and end of each week) and weekly thereafter, detailed observations were recorded at the following times in relation to dose administration: Pre-exposure observation, During dosing, Post exposure, up to 1.5 hours after dosing
BODY WEIGHT: Yes
- Time schedule for examinations: One week before treatment started, on the day treatement started, weekly during treatment, and on the day of necropsy. Females were also weighed on gestation Days 0, 7, 1, and 20 and on lactation Days 1, 4, 7, 14, 21 and 25.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean weekly diet consumption calculated as g food/rat/week: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
OTHER: - Oestrous cyclicity (parental animals):
- Vaginal smears taken daily for 22 days before pairing (including the day of pairing)
- Sperm parameters (parental animals):
- Parameters examined in p and F1 male parental generations: testis weight, epididymis weight, sperm count in testes, sperm count in epididymides, enumeration of cauda epididymal sperm reserve, sperm motility, sperm morphology
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of 10 pups/litter (5/sex/litter as nearly as possible); excess pups were killed and discarded.
PARAMETERS EXAMINED
The following parameters were examined in F1 / F2 offspring: number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, weight gain, physical or behavioural abnormalities
GROSS EXAMINATION OF DEAD PUPS: yes, for external and internal abnormalities - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals when the majority of litters had been weaned.
- Maternal animals: All surviving animals after their respective litter was weaned.
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGHTS
The tissues indicated below were prepared for microscopic examination and weighed*, respectively.
Adrenals*
Brain*
Epididymis (right)*
Heart*
Ovaries*
Pituitary*
Prostate*
Sciatic nerves (females only)
Seminal vesicles
Spinal cord
Spleen
Testis (right)*
Uterus with cervix and oviducts*
Vagina
Other organs and tissues showing any abnormalities - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at 30 days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations including the cervical, thoracic, and abdominal viscera.
HISTOPATHOLOGY / ORGAN WEIGTHS
The tissues indicated below were prepared for microscopic examination (but not evaluated) and weighed*, respectively.
Brain*
Epididymides
Ovaries
Prostate
Seminal vesicles
Spleen*
Testes
Thymus*
Uterus with cervix and oviducts
Vagina
Other tissues or organs with macroscopic abnormalities - Reproductive indices:
- Pre-cital inerval: time elapsing between initial pairing and mating
Percentage mating = Number animals mating/ Animals paired x 100
Conception rate (%) = Number animals achieveing pregnancy/Animals mated x 100
Fertility index (%) = Number of aniamls achieveing pregnancy/Animals pairing x 100
Gestation length: number of gestation days up to and including the day on which the first offspring are observed
Gestation index (%) = Number of live litters born/Number pregnant x 100
Post implanatation survival index (%) = Total number of offspring born/Total number of uterine implantation sites X 100
Live birth index (%) = Number of live offspring on Day 1 after littering/Total number of offspring born X 100
Viability index (%) = Number of live offspring on Day 4 before culling/Number live offspring on Day 1 after littering x100
Lactation index (%) = Number of live offspring on Day 21 after littering/Number of live offspring on Day 4 (after culling)
Percentage males = Number of males in litter/Total number of offspring in litter x 100 - Offspring viability indices:
- Offspring viability indices
- number of pups delivered (live- and stillborn)
- number of live pups (daily)
- number of pups lost measured as above (daily)
- number of litters lost entirely
- number of male pups at day 1,4, 21
- number of implantation sites
- number of lost implantations
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- mortality in the highest dose group
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- Mortality in the F0 generation:
There were 9 female decedents in the F0 generation, 1 at 2000 ppm and 8 at 20000 ppm.
The decedent at 2000 ppm (no 151) was sacrificed following prolonged parturition. In isolation and in the absence of any effects on parturition at higher concentrations of HFO-1234ze, this is considered unrelated to the test article.
At 20000 ppm one female (no 208) was sacrificed on Day 19 of gestation due to poor condition and apparent blood in the vagina. Marked centrilobular hepatocyte necrosis was seen in the liver histologically and this was identified as a factor contributing to death. No other findings were noted in other animals in this group at late gestation so in isolation this death is considered to be unrelated to the test article.
The remaining 7 decedents at 20000 ppm are considered to be due to the test article and all occurred in late lactation (between Days 11 and 21 post partum). Four animals at 20000 ppm were found dead (no.s 212, 213, 215 and 216); a factor contributory to death was undetermined histologically for these 4 females. Three animals at 20000 ppm were sacrificed due to limited use of hindlimbs (no.s 201, 202 and 218). In female 201, marked neuronal necrosis, moderate swelling of astrocytes with vacuolation of the neuropil, slight haemorrhage and moderate gliosis were seen in the cerebellum with moderate gliosis, moderate vacuolation of the neuropil and moderate neuronal loss of the lumbar spinal cord, along with moderate murine progressive cardiomyopathy with an atrial thrombus in the heart; the factor contributing to death was brain lesions. Minimal or slight murine progressive cardiomyopathy was seen in the hearts of females 218 and 202, with minimal neuronal necrosis and neuronal loss seen in the brain of female 202, but the factor contributing to death was undetermined in these females. Clinically loss/limited use of hindlimbs accompanied by abnormal gait and underactive behaviour was seen in some or all these animals. - Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Endocrine findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Treatment related findings were observed in the heart, brain and spinal cord of females at 20000 ppm
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Effect levels (P0)
open allclose all
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- > 20 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No effects on any reproductive parameter
- Key result
- Dose descriptor:
- NOEL
- Effect level:
- 5 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Systemic toxicity / mortality
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- mortality in the highest dose group
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- mortality observed, treatment-related
- Description (incidence and severity):
- Mortality in the F1 generation:
There were 3 female decedents in the F1 generation at 20000 ppm, all occurring in the lactation phase. Two females (no.s 471 on Day 14 post partum and 470 on Day 15 post partum) were found dead in the cage at the initial animal check. No clinical signs had been noted previously. No factors contributing to death were established in these females. A third female (no 475) was sacrificed on Day 24 post partum due to poor condition. This death occurred 12 days after treatment had been terminated; no factor contributing to death was determined and due to the timing of the death of this female not replicating those seen in the F0 generation, this is considered unrelated to HFO-1234ze.
Following the deaths of females 470 and 471, administration of HFO-1234ze to the remaining females at 20000 ppm was terminated, as the effects seemed to replicate those in the F0 generation females during lactation. - Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Bodyweight gain of the F1 generation up to weaning at 20000 ppm from Day 7 for males and Day 4 for females was slightly lower than the Controls. Slightly lower bodyweights persisted throughout the F1 generation.
Bodyweight of males and females F1 generation offspring derived from parents exposed at 20000 ppm was slightly reduced from Day 7 for male offspring and Day 4 post cull for female offspring (up to 0.90 X Control for males and 0.88X Control for females).
There were considered to be no effects on bodyweight at the lower exposure concentrations; whilst group mean bodyweight was lower than the controls at 2000 ppm, there was no difference at 5000 ppm and as such the lower weights at 2000 ppm are considered unrelated to HFO-1234ze. - Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- no effects observed
Effect levels (F1)
- Key result
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- > 20 000 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No effects on any reproductive parameter
Overall reproductive toxicity
- Key result
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- In this study, groups of 28 CD rats/sex/group were exposed to the test substance by inhalation to 0 (sham control), 2000 ppm, 5000 ppm and 20000 ppm for two generations. There were no effects on reproductive indexes, food consumption, clinical observations, organ weights or histopathological observations in the parental animals. There were no effects on development, sexual maturation, litter size, litter survival, litter sex ratio, clinical observations, organ weights or macroscopic findings in the pups from either generation. At 20000 ppm, there were 7 F0 generation female decedents during late lactation (between Day 11 to 21), and 2 F1 generation female decedents during late lactation (Day 14 and 15). Three of the F0 generation decedents were sacrificed following hindlimb paralysis. Brain lesions were established as the cause of death in one F0 generation female. The cause of death for the remaining females was not determined. Due to the fact that mortality was only observed in the high exposure level group, this was considered to be related to the exposure to the test article. The NOEL for paternal (systemic) toxicity was therefore considered to be 5000 ppm. The NOEL for fertility and development was 20000 ppm, because no adverse effects on fertility parameters or offspring were observed.
- Executive summary:
In this study, groups of 28 CD rats/sex/group were exposed to the test substance by inhalation to 0 (sham control), 2000 ppm, 5000 ppm and 20000 ppm for two generations. There were no effects on reproductive indexes, food consumption, clinical observations, organ weights or histopathological observations in the parental animals. There were no effects on development, sexual maturation, litter size, litter survival, litter sex ratio, clinical observations, organ weights or macroscopic findings in the pups from either generation. At 20000 ppm, there were 7 F0 generation female decedents during late lactation (between Day 11 to 21), and 2 F1 generation female decedents during late lactation (Day 14 and 15). Three of the F0 generation decedents were sacrificed following hindlimb paralysis. Brain lesions were established as the cause of death in one F0 generation female. The cause of death for the remaining females was not determined. Due to the fact that mortality was only observed in the high exposure level group, this was considered to be related to the exposure to the test article. The NOEL for paternal (systemic) toxicity was therefore considered to be 5000 ppm. The NOEL for fertility and development was 20000 ppm because no adverse effects on fertility parameters or offspring were observed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)